60076-09-7

Usage

Uses

Used in Pharmaceutical Research:
m-Iodobenzylchloride is used as a building block for the preparation of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
m-Iodobenzylchloride is used as a reagent in the synthesis of biologically active molecules, playing a crucial role in the creation of compounds with potential applications in medicine and other fields.
Used in Agrochemicals Production:
m-Iodobenzylchloride is used as an intermediate in the synthesis of agrochemicals, aiding in the development of products for agricultural applications.
Used in Specialty Chemicals Manufacturing:
m-Iodobenzylchloride is used as an intermediate in the manufacturing of specialty chemicals, contributing to the production of unique and high-value chemical products.
Safety Precautions:
m-Iodobenzylchloride is potentially harmful if inhaled, ingested, or comes into contact with the skin. Therefore, appropriate safety measures should be taken when handling this chemical to minimize health risks.

Upstream product

• 57455-06-8 3-iodobenzylalcohol 
• 10026-13-8 phosphorus pentachloride 

Downstream Products

• 77148-94-8 2-((3-Iodobenzyl)thio)-1-methylpyridinium chloride 
• 887139-21-1 {4-[1-(3-iodo-benzyl)-5-oxo-1,5-dihydro-[1,2,4]triazol-4-yl]-benzyl}-methyl-carbamic acid tert-butyl ester 
• 887139-77-7 2-(3-iodo-benzyl)-4-(4-methylaminomethyl-phenyl)-2,4-dihydro-[1,2,4]triazol-3-one 
• 130504-76-6 m-iodobenzyl cholesteryl ether 
• 474010-13-4 dimethyl (3-iodobenzyl)malonate 
• 1309459-57-1 3-(1-hydroxy-2-(3-iodophenyl)ethyl)benzonitrile 

Relevant academic research and scientific papers

HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

The present invention relates to compounds of general formula (I), wherein D 1 to D 3, -A-, n, R 1, R 2, Y 1, L and y2 are defined as in claim 1, which have valuable pharmacological propert

THIAZOLE AND OXAZOLE KINASE INHIBITORS

The present invention is concerned with substituted azole derivatives that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant proteine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. In particular, several of these compounds are potent and selective Flt-3 inhibitors or/and syk inhibitors.

PYRROLE DERIVATIVE

A novel pyrrole derivative represented by the following formula (1) and a salt thereof: wherein R1 means substituted alkenyl, etc.; R2 means substituted benzoyl, etc.; and R3 to R5 each means hydrogen, alkyl, halogeno, etc. The derivative and salt have antidiabetic activity.

Amines useful as brain imaging agents

Certain radioiodine containing amines useful as brain imaging agents are disclosed. The compounds of the invention are represented by the formula STR1 wherein I is a radioisotope of iodine with I-123 being preferred, R is lower alkyl or halogen, R1 and R2 are the same or different and are selected from the group consisting of hydrogen and lower alkyl, R3 and R4 are the same or different and are selected from the group consisting of hydrogen, alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl and substituted carbamoyl methyl or R3 and R4 taken together with the nitrogen to which they are attached form a 5- or 6-membered ring which may be substituted with one or more lower alkyl groups, x is 0 to 4, y is 0 to 3 and z is 0 or 1 and pharmaceutically acceptable acid addition salts thereof.